#biotechnology #Switzerland #ACROBiosystems #Zurich #Innovation Day

ACROBiosystems Innovation Day: A Gathering of Biotech Innovators

On May 12, 2026, ACROBiosystems hosted a highly anticipated Innovation Day at the Superlab Suisse Zürich Schlieren, located in the dynamic landscape of Zurich, Switzerland. This event attracted a vibrant assembly of leading scientists, researchers in translational science, and innovators from the biotech industry, all converging to explore the latest advances in biologic drug development and driving innovations in the field.

The atmosphere was charged with excitement and creativity, showcasing a melting pot of ideas through stimulating discussions and invaluable networking opportunities. The Innovation Day was conceptualized to investigate emerging technologies, evolving regulatory frameworks, and fresh strategies that streamline the journey from discovery to clinical application.

Exciting Presentations from Leading Experts

One of the key highlights of the event was Dr. Lili Qin, Vice President of Research and Development at ACROBiosystems, who presented on the impactful integration of AI in protein engineering. Her talk, titled "AI-Powered Next-Generation Protein Engineering in CGT," detailed how AI techniques are revolutionizing the entire protein development workflow—ranging from structure predictions to expression optimization. Dr. Qin illustrated the efficacy of AI in enhancing protein yield through concrete examples, including an AI-optimized cytokine, resulting in a remarkable 20-fold increase in expression yield.

The discussions continued with Dr. Jenny Ann Prange, Head of Project Management at Wyss Zurich's Regenerative Medicine Technologies Platform, who shared critical insights on the often-challenging transition from exploratory research to a regulated environment. In her talk, "Translating Ideas to Reach The Ones in Need," she elaborated on how the Wyss Zurich platform supports unique projects through funding and resources, ensuring they navigate complex regulatory pathways successfully.

Clinical insights were shared by Dr. Chiara Magnani from University Hospital Zürich and University of Zürich, who presented groundbreaking results in CAR T-cell therapy, achieving an 83% complete remission rate in treated patients. Her presentation emphasized the potential of innovative engineering methods to overcome the challenges of immune suppression in tumor microenvironments.

Dr. Fabien Jammes from Limula addressed the pressing challenges faced in cell therapy manufacturing. In his presentation, "Decentralised Manufacturing of Cell Therapies: How Compact Automation is Changing the Landscape," he showcased Limula's innovative all-in-one platform that merges the functions of bioreactors and centrifuges. This transformative technology promises to decentralize production, making therapies more accessible and affordable.

Furthermore, discussions led by Dr. Agnese Pisano and Dr. Aaron Debon at INOFEA revolved around enzyme immobilization techniques for enhancing stability and productivity in biologics manufacturing. Their innovative strategies presented a pathway for improving the efficiency of mRNA and antibody-drug conjugate production.

Fostering Collaboration for Future Success

The array of presentations underscored both prospects and challenges within the realm of modern biologic development. Despite differing perspectives, all speakers reiterated the importance of collaboration in driving breakthroughs and fostering innovation.

A participant, Giacomo Cattaruzzi, Innovation Director at Muvon Therapeutics AG remarked, "This is a great event gathering both academic and industry leaders. I look forward to future events like this — please keep me posted."

ACROBiosystems' Chairman, Mike Chen, expressed satisfaction over the event's success, stating, “We are committed to promoting global biotech innovation and look forward to continuing meetings like this that contribute meaningfully to the industry’s advancement.”

A Leader in Biotech Innovation

Established in 2010, ACROBiosystems is dedicated to becoming a pivotal player in the global biopharmaceutical and healthcare sectors, focusing on innovative solutions and collaborative networks. With a presence in over 15 cities across the United States, Switzerland, the United Kingdom, and Germany, the company maintains strong partnerships with renowned pharmaceutical companies and academic institutions.

Through continuous technological advancements and product development, ACROBiosystems empowers the pharmaceutical industry, emphasizing progress in drug development processes, from targeted therapies to immunotherapeutics.

The Innovation Day served as a platform for fruitful exchanges and collaboration, setting a strong foundation for future innovations in biotechnology as ACROBiosystems continues its journey toward groundbreaking discoveries in healthcare.